Immunic, Inc.
IMUX· Nasdaq
Released Aug 4, 2022, before the open
10-Q filed Aug 4, 2022, 35 days after period end · 0001280776-22-000017
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Net Income | -$21.90M | -$17.93M | -$11.46M | -$14.71M |
| EPS Diluted | -$0.72 | -$0.82 | -$0.90 | -$1.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR